(0671–0710) Systemic Sclerosis & Related Disorders – Clinical Poster I

Sunday, October 26, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

A Randomised Open Label Pilot Trial Comparing Mycophenolate Mofetil with No Immunosuppression in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)
Abstract Poster Presenter: Christopher Denton, MD, PhD (he/him/his) – University College London
10:30 AM - 12:30 PM Central Time

A Retrospective Comparison of Transplant Outcomes in Patients with and Without Systemic Sclerosis
Abstract Poster Presenter: Lilit Grigoryan, DO – Albany Medical College
10:30 AM - 12:30 PM Central Time

A Retrospective Comparison of Transplant Outcomes with Different Induction Methods and Maintenance Prednisone in Systemic Sclerosis Patients
Abstract Poster Presenter: Lilit Grigoryan, DO – Albany Medical College
10:30 AM - 12:30 PM Central Time

Altered Mirna Patterns of Peripheral Blood Mononuclear Cells Show Correlations with Pulmonary Manifestations of Systemic Sclerosis
Abstract Poster Presenter: Zoltan Szekanecz, MD, PhD – University of Debrecen
10:30 AM - 12:30 PM Central Time

Association Between Vasoactive-vasodilating Therapy and Reduced Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis: Evidence from a EUSTAR Study
Abstract Poster Presenter: Cosimo Bruni, MD, PhD – University of Zurich
10:30 AM - 12:30 PM Central Time

Association of Choroidal Sub-foveal Thickness with Skin Manifestations and Serum Monocyte HDL Ratio in Patients with Systemic Sclerosis-a Case Control Study
Abstract Poster Presenter: Tejaswini Ramineni, n/a (she/her/hers) – Esic Medical College And Hospital, Sanathnagar
10:30 AM - 12:30 PM Central Time

Association of Elevated Platelets and CRP with Severe Disease and Poor Survival in Systemic Sclerosis
Abstract Poster Presenter: Brian Lee, MD, MS, FACP – Stanford University
10:30 AM - 12:30 PM Central Time

Determinants of Progressive Microstomia in Systemic Sclerosis: Insights from the GENISOS Cohort with a Focus on GI Involvement
Abstract Poster Presenter: Ashish Balar, MBBS, MPH – The University of Texas Health Science Center Houston
10:30 AM - 12:30 PM Central Time

Development of an Articular Activity Score in Systemic Sclerosis (ASSESS): Identifying Core Instruments for Disease Activity Assessment
Abstract Poster Presenter: Blaz Burja, MD – Zurich, Switzerland
10:30 AM - 12:30 PM Central Time

Distinct Breath Metabolomic Signature in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension
Abstract Poster Presenter: Lorenzo Beretta, MD – Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di MIlano
10:30 AM - 12:30 PM Central Time

Distinct Cancer Risk Profiles in Patients with Systemic Sclerosis with Autoantibody Stratification
Abstract Poster Presenter: Arjun Mahajan, MS – Harvard Medical School
10:30 AM - 12:30 PM Central Time

Effectiveness of Oral Anticoagulants in Precapillary Pulmonary Hypertension Associated with Systemic Sclerosis: a EUSTAR Cohort Study.
Abstract Poster Presenter: Nicola Farina, MD – IRCCS San Raffaele Hospital
10:30 AM - 12:30 PM Central Time

Engineered glove for the objective assessment of hand dexterity in patients with systemic sclerosis: correlations with clinical features, nailfold videocapillaroscopy, and high frequency skin ultrasonography
Abstract Poster Presenter: Elvis Hysa, MD – University of Genova
10:30 AM - 12:30 PM Central Time

Evaluation of Serial Cardiovascular Magnetic Resonance Monitoring and Immunosuppressive Therapy in Predicting Long-Term Outcomes in Systemic Sclerosis
Abstract Poster Presenter: Aïcha Kante, MD, MSc – Université Paris Cité
10:30 AM - 12:30 PM Central Time

Exploring Calcinosis On Hand X-Rays In Systemic Sclerosis: a Mayo Clinic Cohort
Abstract Poster Presenter: Maximiliano Diaz Menindez, MD (he/him/his) – Mayo Clinic School of Graduate Medical Education
10:30 AM - 12:30 PM Central Time

Global Longitudinal, Circumferential, and Radial Strain in Systemic Sclerosis Patients with Left Ventricular Dysfunction
Abstract Poster Presenter: Jennifer Abdalla, MD, MS – LSU Health Sciences Center
10:30 AM - 12:30 PM Central Time

Human Pharmacokinetics of Inhaled Liposomal Iloprost Support a Dosing Regimen for Treating Systemic Sclerosis- Related Digital Ulcer
Abstract Poster Presenter: Pei Kan, n/a (he/him/his) – Pharmosa Biopharm Inc
10:30 AM - 12:30 PM Central Time

Impact of X Chromosome Dosage on the Development of Diffuse and Limited Systemic Sclerosis in Klinefelter, Triple X, and Turner Syndromes: A Multicenter Cohort Study
Abstract Poster Presenter: Hanieh Akbari, MD – Jefferson Einstein Montgomery Medical Center
10:30 AM - 12:30 PM Central Time

Increased incidence of sudden cardiac death in systemic sclerosis: estimate & correlates.
Abstract Poster Presenter: Laura Ross, MBBS PhD FRACP – The University of Melbourne
10:30 AM - 12:30 PM Central Time

Inhibition of TGFb3 in Systemic Sclerosis Patients Does Not Result in TGFb Pathway Modulation in Skin Biopsies or Circulation
Abstract Poster Presenter: Xuting (Rebecca) Sheng, PhD – Genentech
10:30 AM - 12:30 PM Central Time

Major salivary glands Ultrasound features in a group of patients with systemic sclerosis: a multicentric study
Abstract Poster Presenter: Roberto D'Alessandro, MS – APHP
10:30 AM - 12:30 PM Central Time

Multimodal Imaging Evaluation of Patients with Raynaud's Phenomenon meeting the Criteria for "Early" Systemic Sclerosis according to LeRoy versus Healthy Controls: a Prospective Cross-sectional study
Abstract Poster Presenter: RAMONA GOVENDER, MBChB, MMed – University of Ghent
10:30 AM - 12:30 PM Central Time

Neutrophil-to-Lymphocyte Ratio as a biomarker for disease onset and a predictor for mortality in Systemic Sclerosis – real-world data from a large healthcare provider in Israel.
Abstract Poster Presenter: Doron Rimar, MD (he/him/his) – Bnai Zion medical center
10:30 AM - 12:30 PM Central Time

Predictors of Severe Outcomes in Scleroderma Renal Crisis: Updated Results from a Single Center Study
Abstract Poster Presenter: Alex Luta, MD – Hospital for Special Surgery
10:30 AM - 12:30 PM Central Time

Quantitative Imaging in Systemic Sclerosis Patients Receiving Sodium Thiosulfate for Calcinosis Cutis
Abstract Poster Presenter: Crystal Cheung, MS – Yale University
10:30 AM - 12:30 PM Central Time

Quantitative ¹⁸F-FDG PET-CT of the lungs detects treatment induced changes in patients with early severe diffuse cutaneous systemic sclerosis and interstitial lung disease
Abstract Poster Presenter: Bo Broens, MD – Amsterdam UMC
10:30 AM - 12:30 PM Central Time

Symptom-Based Clustering of Gastrointestinal Involvement in Systemic Sclerosis
Abstract Poster Presenter: Ali Ayla, MD – UPMC
10:30 AM - 12:30 PM Central Time

Systemic Sclerosis Inducible Pluripotential Stem Cells Reprogrammed into Endothelial Cells Identify Vascular Permeability May Not Be Cytokine Driven
Abstract Poster Presenter: Tracy Frech, MD, MS – Vanderbilt University Medical Center
10:30 AM - 12:30 PM Central Time

Targeting Refractory Reflux in Systemic Sclerosis: Early Outcomes following a Novel Intervention
Abstract Poster Presenter: Areeka Memon, DO, MPH – Yale New Haven Health
10:30 AM - 12:30 PM Central Time

Targeting the plasma cell niche in systemic sclerosis: A case series about the bispecific anti-BCMAxCD3 antibody teclistamab in severe, treatment-refractory patients
Abstract Poster Presenter: Wolfgang Merkt, MD – University Hospital Düsseldorf
10:30 AM - 12:30 PM Central Time

The Gut-Heart Axis in Systemic Sclerosis: Evidence from the GENISOS cohort
Abstract Poster Presenter: Ali Ayla, MD – UPMC
10:30 AM - 12:30 PM Central Time

Total lung capacity is predictive of disease severity and survival in systemic sclerosis: a longitudinal analysis in 2347 patients from the French National Cohort Study
Abstract Poster Presenter: Benjamin Chaigne, MD, PhD – Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Cochin University Hospital, Université Paris Cité, AP-HP
10:30 AM - 12:30 PM Central Time

Translation to Spanish and Linguistic Validation of the Assessment of Systemic Sclerosis-associated Raynaud's Phenomenon (ASRAP)
Abstract Poster Presenter: Antonia Valenzuela, MD, MS – Pontificia Universidad Catolica de Chile
10:30 AM - 12:30 PM Central Time

Treatment of Sjögren’s disease by blocking FcRn: clinical and translational data from RHO, a phase 2 randomized, placebo controlled, double-blind, proof-of-concept study with efgartigimod
Abstract Poster Presenter: isabelle peene, MD,PhD – University Hospital Ghent
10:30 AM - 12:30 PM Central Time

Trends and Disparities in Systemic Sclerosis-related Mortality Rates in the United States from 1999 to 2023
Abstract Poster Presenter: Nicolas Barnechea Alvarado, MD (he/him/his) – Kirk Kerkorian School of Medicine at UNLV
10:30 AM - 12:30 PM Central Time

Use of a Smartphone App which Incorporates Feedback to Patients to Monitor Systemic Sclerosis-related Digital Ulcers – a Potential New Tool for Remote Clinical Monitoring
Abstract Poster Presenter: Ariane Herrick, MD – The University of Manchester, UK
10:30 AM - 12:30 PM Central Time

Vascular Events in Systemic Sclerosis Patients with Anti-Phospholipid Antibodies
Abstract Poster Presenter: Vivian Shing, BS – Mayo Clinic Alix School of Medicine
10:30 AM - 12:30 PM Central Time

When Can Support Lead to Missed Clinic Appointments in Patients with Systemic Lupus Erythematosus?
Abstract Poster Presenter: Samiha Karim, MD – Emory University
10:30 AM - 12:30 PM Central Time

WITHDRAWN